World Wildlife Fund ceo to keynote FMI Sustainability Summit
ARLINGTON, Va. Carter Roberts, president and ceo of the World Wildlife Fund, will be the keynote speaker at the Food Marketing Institute Food Industry Sustainability Summit June 16 to 18, which will offer those in the food retail industry a chance to learn how they can be more “green.”
Roberts will discuss how to use the market to fight climate change and resource exhaustion. As head of the world’s largest conservation organization, he will discuss how a new era of global threats has changed the way many institutions address conservation.
The summit will also include general sessions, interactive forums, workshops and case studies will address strategic issues and offer practical solutions for food retailers and wholesalers who seek to differentiate their company by optimizing their sustainability programs. Industry leaders and sustainability experts from business, government, academia and advocacy groups will share their success stories.
CVS reports on effects of e-prescribing
WOONSOCKET, R.I. CVS Caremark and Horizon Blue Cross Blue Shield of New Jersey will present data that shows how the iScribe e-prescribing tool can allow for the objective identification and assessment of medication noncompliance to enable appropriate patient intervention at the 20th annual meeting of the Academy of Managed Care Pharmacy on April 18. The study, conducted in conjunction with Horizon BCBSNJ, analyzed when and if prescriptions written for the treatment of various chronic conditions, such as cardiovascular disease, were dispensed to patients.
iScribe is an intuitive, easy-to-use e-prescribing product that prescribers report they can begin using within 15 to 30 minutes of picking up their PDA. With iScribe, prescribers can send prescriptions securely and directly to the patient’s pharmacy of choice from either a handheld PDA or desktop computer. iScribe provides the prescriber with generic and formulary coverage information, assisting the physician in selecting the most cost-effective medication for their patients.
Study results found a high rate of noncompliance among all patients taking medications to treat a variety of cardiovascular diseases such as high blood pressure, with approximately 18% of those prescriptions unfilled after 60 days. Patients continuing their therapy were found to be significantly more compliant than those starting a new therapy with a cardiovascular medication. Noncompliance among patients continuing therapy was approximately 6%, while noncompliance rates for patients initiating therapy with a cardiovascular medication (i.e., primary noncompliance) were much higher, with up to 70% of patients noncompliant after 60 days.
“While it is widely recognized that medication noncompliance contributes to adverse drug events, poor health outcomes and increased health care costs, research to date has focused on patients who discontinue therapy and has not been able to account for primary noncompliance, where medications prescribed to begin therapy are never filled by the patient,” said Jan Berger, MD, chief clinical officer for CVS Caremark. “The data, collected using iScribe e-prescribing technology, shows us not only that there is an extremely high rate of primary noncompliance for medications to treat cardiovascular conditions, which places patients at increased risk for heart attack or stroke, but also provides information that can help shape how and when healthcare providers can most effectively intervene with education and support.”
Data was collected between Jan. 1, 2005 and Oct. 31, 2006 from a subset of 507 Horizon BCBSNJ providers who use iScribe e-prescribing technology. Researchers conducted a retrospective analysis comparing prescriptions for medications to treat chronic diseases (i.e., asthma, cardiovascular diseases, and diabetes) as well as prescriptions for antibiotics written via iScribe during this time period to submitted drug claims for medications dispensed between Jan. 1, 2005 and Dec. 31, 2006.
Linens ‘N Things retains Financo
CLIFTON, N.J. Linens ‘N Things has added investment banking firm Financo as a financial advisor. The company has also retained Conway, Del Genio, Gries & Co. as financial advisor.
“We are committed to exploring all reasonable avenues in our effort to strengthen the company and to adopt a financial solution that recognizes the inherent value of the Linens ‘N Things’ business. Accordingly, we are our expanding our highly capable financial advisory team with the addition of Financo,” said Robert DiNicola, chairman and ceo.